We compared the effect of PTPN2/N1 inhibition to genetic deletion and found that AC484 dose-dependently enhanced IFNγ-driven growth arrest in vitro, comparable to Ptpn2/n1-deficient B16 tumour cells (Fig. 2a,b). Here, IFNG is linked to neoplasm.